{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:01:14Z","timestamp":1784815274595,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12451-0","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:12:08Z","timestamp":1784812328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential methylation of immune-related genes and its clinical significance in systemic lupus erythematosus: insights from TET2, FOXP3, and IFI44L genes"],"prefix":"10.1007","volume":"53","author":[{"given":"Esmat Rigi","family":"Yousefabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Mostafapour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delnya","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoleikha Rigi","family":"Yousefabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bashandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emran","family":"Esmaeilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza Khorram","family":"Khorshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"12451_CR1","doi-asserted-by":"crossref","unstructured":"Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, Zeb S, Tariq MA, Patlolla SR, Ali J (2022) An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus 14(10)","DOI":"10.7759\/cureus.30330"},{"issue":"9","key":"12451_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.36557\/2674-8169.2024v6n9p647-660","volume":"6","author":"VFAJA J\u00fanior","year":"2024","unstructured":"J\u00fanior VFAJA, Silva SM, Amaral AL, Perini JVFV, dos Santos JEN (2024) Systemic lupus erythematosus (SLE): Most common clinical manifestations and renal complications. Brazilian J Implantology Health Sci 6(9):647\u2013660","journal-title":"Brazilian J Implantology Health Sci"},{"key":"12451_CR3","doi-asserted-by":"crossref","unstructured":"Selvaraja M, Abdullah M, Shah AM, Arip M, Nordin SA (2020) Systemic Lupus Erythematosus (SLE): A review on the prevalence, clinical manifestation, and disease assessment. Progress Microbes Mol Biology 3(1)","DOI":"10.36877\/pmmb.a0000106"},{"issue":"3","key":"12451_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12016-021-08917-7","volume":"63","author":"X Huang","year":"2022","unstructured":"Huang X, Zhang Q, Zhang H, Lu Q (2022) A contemporary update on the diagnosis of systemic lupus erythematosus. Clin Rev Allergy Immunol 63(3):311\u2013329","journal-title":"Clin Rev Allergy Immunol"},{"key":"12451_CR5","doi-asserted-by":"crossref","unstructured":"Morand EF, Fernandez-Ruiz R, Blazer A, Niewold TB (2023) Advances in the management of systemic lupus erythematosus. BMJ 383","DOI":"10.1136\/bmj-2022-073980"},{"issue":"11","key":"12451_CR6","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.4103\/jfmpc.jfmpc_1177_24","volume":"13","author":"JL Mitchell","year":"2024","unstructured":"Mitchell JL (2024) Understanding the impact of delayed diagnosis and misdiagnosis of systemic lupus erythematosus (SLE). J Family Med Prim Care 13(11):4819\u20134823","journal-title":"J Family Med Prim Care"},{"issue":"8","key":"12451_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/imj.15448","volume":"51","author":"K Connelly","year":"2021","unstructured":"Connelly K, Morand EF (2021) Systemic lupus erythematosus: a clinical update. Intern Med J 51(8):1219\u20131228","journal-title":"Intern Med J"},{"issue":"1","key":"12451_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae S-C, Boletis J, Bruce IN, Cervera R, Doria A (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83(1):15\u201329","journal-title":"Ann Rheum Dis"},{"key":"12451_CR9","doi-asserted-by":"publisher","unstructured":"Aringer M (2019) EULAR\/ACR classification criteria for SLE. Seminars in arthritis and rheumatism 49 (3): S14-S17 https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.009","DOI":"10.1016\/j.semarthrit.2019.09.009"},{"issue":"1","key":"12451_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/1744666X.2023.2260098","volume":"20","author":"H Ding","year":"2024","unstructured":"Ding H, Shen Y, Hong S-M, Xiang C, Shen N (2024) Biomarkers for systemic lupus erythematosus\u2013a focus on organ damage. Expert Rev Clin Immunol 20(1):39\u201358","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"12451_CR11","doi-asserted-by":"publisher","first-page":"100509","DOI":"10.1016\/j.clinme.2025.100509","volume":"25","author":"J Scopes","year":"2025","unstructured":"Scopes J, Md Yusof MY (2025) Challenges in the diagnosis of systemic lupus erythematosus. Clin Med (Lond) 25(5):100509. https:\/\/doi.org\/10.1016\/j.clinme.2025.100509","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"12451_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/jcm10020243","volume":"10","author":"M Piga","year":"2021","unstructured":"Piga M, Arnaud L (2021) The main challenges in systemic lupus erythematosus: where do we stand? J Clin Med 10(2):243","journal-title":"J Clin Med"},{"key":"12451_CR13","doi-asserted-by":"publisher","first-page":"1501783","DOI":"10.3389\/fimmu.2024.1501783","volume":"15","author":"X Zhou","year":"2025","unstructured":"Zhou X, Zhou S, Li Y (2025) An updated review on abnormal epigenetic modifications in the pathogenesis of systemic lupus erythematosus. Front Immunol 15:1501783","journal-title":"Front Immunol"},{"issue":"2","key":"12451_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/ijms25021019","volume":"25","author":"Y Araki","year":"2024","unstructured":"Araki Y, Mimura T (2024) Epigenetic dysregulation in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci 25(2):1019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12451_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/09612033221148099","volume":"32","author":"N Ehtesham","year":"2023","unstructured":"Ehtesham N, Habibi Kavashkohie MR, Mazhari SA, Azhdari S, Ranjbar H, Mosallaei M, Hazrati E, Behroozi J (2023) DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies. Lupus 32(3):363\u2013379","journal-title":"Lupus"},{"issue":"5","key":"12451_CR16","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10067-022-06495-3","volume":"42","author":"W Zhang","year":"2023","unstructured":"Zhang W, Liang G, Zhou H, Zeng X, Zhang Z, Xu X, Lai K (2023) Identification of potential biomarkers for systemic lupus erythematosus by integrated analysis of gene expression and methylation data. Clin Rheumatol 42(5):1423\u20131433","journal-title":"Clin Rheumatol"},{"issue":"1","key":"12451_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-immunol-080223-044610","volume":"42","author":"IF L\u00f3pez-Moyado","year":"2024","unstructured":"L\u00f3pez-Moyado IF, Ko M, Hogan PG, Rao A (2024) TET enzymes in the immune system: from DNA demethylation to immunotherapy, inflammation, and cancer. Annu Rev Immunol 42(1):455\u2013488","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"12451_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"TS Sumida","year":"2024","unstructured":"Sumida TS, Cheru NT, Hafler DA (2024) The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat Rev Immunol 24(7):503\u2013517. https:\/\/doi.org\/10.1038\/s41577-024-00994-x","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"12451_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00109-016-1421-4","volume":"94","author":"M-L Eloranta","year":"2016","unstructured":"Eloranta M-L, R\u00f6nnblom L (2016) Cause and consequences of the activated type I interferon system in SLE. J Mol Med 94(10):1103\u20131110. https:\/\/doi.org\/10.1007\/s00109-016-1421-4","journal-title":"J Mol Med"},{"key":"12451_CR20","doi-asserted-by":"publisher","unstructured":"Tsagaratou A, Rao A (2013) TET proteins and 5-methylcytosine oxidation in the immune system. Cold Spring Harbor Laboratory Press, 78 (1): pp 1\u201310. https:\/\/doi.org\/10.1101\/sqb.2013.78.020248","DOI":"10.1101\/sqb.2013.78.020248"},{"issue":"4","key":"12451_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.immuni.2015.03.005","volume":"42","author":"K Ichiyama","year":"2015","unstructured":"Ichiyama K, Chen T, Wang X, Yan X, Kim B-S, Tanaka S, Ndiaye-Lobry D, Deng Y, Zou Y, Zheng P (2015) The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42(4):613\u2013626","journal-title":"Immunity"},{"issue":"7569","key":"12451_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang C, Zhang X (2015) Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525(7569):389\u2013393","journal-title":"Nature"},{"issue":"12","key":"12451_CR23","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3390\/diagnostics12123006","volume":"12","author":"W-Y Sung","year":"2022","unstructured":"Sung W-Y, Lin Y-Z, Hwang D-Y, Lin C-H, Li R-N, Tseng C-C, Wu C-C, Ou T-T, Yen J-H (2022) Methylation of TET2 promoter is associated with global hypomethylation and hypohydroxymethylation in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Diagnostics 12(12):3006","journal-title":"Diagnostics"},{"issue":"11","key":"12451_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nri.2017.75","volume":"17","author":"L Lu","year":"2017","unstructured":"Lu L, Barbi J, Pan F (2017) The regulation of immune tolerance by FOXP3. Nat Rev Immunol 17(11):703\u2013717","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"12451_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.13178","volume":"160","author":"M Ono","year":"2020","unstructured":"Ono M (2020) Control of regulatory T-cell differentiation and function by T\u2010cell receptor signalling and Foxp3 transcription factor complexes. Immunology 160(1):24\u201337","journal-title":"Immunology"},{"issue":"5","key":"12451_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/ard.2007.074690","volume":"67","author":"M Bonelli","year":"2008","unstructured":"Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C (2008) Foxp3 expression in CD4\u2009+\u2009T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann Rheum Dis 67(5):664\u2013671","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"12451_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.it.2014.06.005","volume":"35","author":"J van Loosdregt","year":"2014","unstructured":"van Loosdregt J, Coffer PJ (2014) Post-translational modification networks regulating FOXP3 function. Trends Immunol 35(8):368\u2013378","journal-title":"Trends Immunol"},{"issue":"11","key":"12451_CR28","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","volume":"75","author":"M Zhao","year":"2016","unstructured":"Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, Liu Y, Jiang J, Luo S, Tan Y (2016) IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis 75(11):1998\u20132006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"12451_CR29","first-page":"48","volume":"41","author":"Y Wang","year":"2022","unstructured":"Wang Y, Jia W, Ma Q, Li F, Ma Z, Yang M, Pu J, Huo Z, Dang J (2022) Identification of IFI44L as a new candidate molecular marker for systemic lupus erythematosus. Clin Exp Rheumatol 41(1):48\u201359","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"12451_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/0471142735.im0701s85","volume":"85","author":"IJ Fuss","year":"2009","unstructured":"Fuss IJ, Kanof ME, Smith PD, Zola H (2009) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr protocols Immunol 85(1): 7.1. 1-7.1. 8","journal-title":"Curr protocols Immunol"},{"issue":"12","key":"12451_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/labinvest.2008.100","volume":"88","author":"M Bettstetter","year":"2008","unstructured":"Bettstetter M, Dechant S, Ruemmele P, Vogel C, Kurz K, Morak M, Keller G, Holinski-Feder E, Hofstaedter F, Dietmaier W (2008) MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples. Lab Invest 88(12):1367\u20131375","journal-title":"Lab Invest"},{"issue":"2","key":"12451_CR32","first-page":"155","volume":"22","author":"E Rigi Yousefabadi","year":"2025","unstructured":"Rigi Yousefabadi E, Ourang Z, Gharibdoost F, Faezi ST, Saatchi M, Gholami D, Esmaeilzadeh E, Khorram Khorshid HR (2025) Hypomethylation of OAS2 and OAS3 Gene Promoters: Insights into the Pathogenesis of Systemic Lupus Erythematosus. Iran J Immunol 22(2):155\u2013164","journal-title":"Iran J Immunol"},{"key":"12451_CR33","doi-asserted-by":"publisher","unstructured":"Luo S, Wu R, Li Q, Zhang G (2022) Epigenetic Regulation of IFI44L Expression in Monocytes Affects the Functions of Monocyte-Derived Dendritic Cells in Systemic Lupus Erythematosus. J Immunol Res 2022(4053038). https:\/\/doi.org\/10.1155\/2022\/4053038","DOI":"10.1155\/2022\/4053038"},{"issue":"3","key":"12451_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1084\/jem.20151438","volume":"213","author":"X Yue","year":"2016","unstructured":"Yue X, Trifari S, \u00c4ij\u00f6 T, Tsagaratou A, Pastor WA, Zepeda-Mart\u00ednez JA, Lio CW, Li X, Huang Y, Vijayanand P, L\u00e4hdesm\u00e4ki H, Rao A (2016) Control of Foxp3 stability through modulation of TET activity. J Exp Med 213(3):377\u2013397. https:\/\/doi.org\/10.1084\/jem.20151438","journal-title":"J Exp Med"},{"issue":"2","key":"12451_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.immuni.2015.07.017","volume":"43","author":"R Yang","year":"2015","unstructured":"Yang R, Qu C, Zhou Y, Konkel JE, Shi S, Liu Y, Chen C, Liu S, Liu D, Chen Y (2015) Hydrogen sulfide promotes Tet1-and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis. Immunity 43(2):251\u2013263","journal-title":"Immunity"},{"key":"12451_CR36","doi-asserted-by":"publisher","unstructured":"Sung WY, Lin YZ, Hwang DY, Lin CH, Li RN, Tseng CC, Wu CC, Ou TT, Yen JH (2022) Methylation of TET2 Promoter Is Associated with Global Hypomethylation and Hypohydroxymethylation in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients. Diagnostics (Basel) 12(12). https:\/\/doi.org\/10.3390\/diagnostics12123006","DOI":"10.3390\/diagnostics12123006"},{"issue":"2","key":"12451_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2567.2008.02937.x","volume":"127","author":"JL Suen","year":"2009","unstructured":"Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH (2009) Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 127(2):196\u2013205. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02937.x","journal-title":"Immunology"},{"key":"12451_CR38","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3389\/fimmu.2019.02606","volume":"10","author":"RC Ferreira","year":"2019","unstructured":"Ferreira RC, Castro Dopico X, Oliveira JJ, Rainbow DB, Yang JH, Trzupek D, Todd SA, McNeill M, Steri M, Orr\u00f9 V (2019) Chronic immune activation in systemic lupus erythematosus and the autoimmune PTPN22 Trp620 risk allele drive the expansion of FOXP3\u2009+\u2009regulatory T cells and PD-1 expression. Front Immunol 10:2606","journal-title":"Front Immunol"},{"issue":"13","key":"12451_CR39","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1177\/0961203318804881","volume":"27","author":"Z Yin","year":"2018","unstructured":"Yin Z, Ju B, Zhu L, Hu N, Luo J, He M, Feng X, Lv X, Pu D, He L (2018) Increased CD4\u2009+\u2009CD25-Foxp3\u2009+\u2009T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement. Lupus 27(13):2057\u20132068","journal-title":"Lupus"},{"issue":"4","key":"12451_CR40","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","volume":"178","author":"X Valencia","year":"2007","unstructured":"Valencia X, Yarboro C, Illei G, Lipsky PE (2007) Deficient CD4\u2009+\u2009CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178(4):2579\u20132588","journal-title":"J Immunol"},{"issue":"7","key":"12451_CR41","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.4049\/jimmunol.1203473","volume":"190","author":"A Toker","year":"2013","unstructured":"Toker A, Engelbert D, Garg G, Polansky JK, Floess S, Miyao T, Baron U, D\u00fcber S, Geffers R, Giehr P (2013) Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J Immunol 190(7):3180\u20133188","journal-title":"J Immunol"},{"issue":"4","key":"12451_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.aller.2020.03.014","volume":"48","author":"S Hanaei","year":"2020","unstructured":"Hanaei S, Sanati G, Zoghi S, Gharibzadeh S, Ziaee V, Rezaei N (2020) The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus. Allergol Immunopathol 48(4):332\u2013338","journal-title":"Allergol Immunopathol"},{"issue":"9","key":"12451_CR43","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","volume":"72","author":"T Alexander","year":"2013","unstructured":"Alexander T, Sattler A, Templin L, Kohler S, Gro\u00df C, Meisel A, Sawitzki B, Burmester G-R, Arnold R, Radbruch A (2013) Foxp3\u2009+\u2009Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Ann Rheum Dis 72(9):1549\u20131558","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"12451_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/08820139.2014.938165","volume":"44","author":"O Ngalamika","year":"2015","unstructured":"Ngalamika O, Liang G, Zhao M, Yu X, Yang Y, Yin H, Liu Y, Yung S, Chan TM, Lu Q (2015) Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections. Immunol Invest 44(2):126\u2013136. https:\/\/doi.org\/10.3109\/08820139.2014.938165","journal-title":"Immunol Invest"},{"issue":"3","key":"12451_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cei.13357","volume":"199","author":"G Deng","year":"2020","unstructured":"Deng G, Song X, Greene M (2020) FoxP3 in Treg cell biology: a molecular and structural perspective. Clin Experimental Immunol 199(3):255\u2013262","journal-title":"Clin Experimental Immunol"},{"key":"12451_CR46","doi-asserted-by":"publisher","first-page":"108267","DOI":"10.1016\/j.clim.2019.108267","volume":"209","author":"C Jiang","year":"2019","unstructured":"Jiang C, Wang H, Xue M, Lin L, Wang J, Cai G, Shen Q (2019) Reprograming of peripheral Foxp3\u2009+\u2009regulatory T cell towards Th17-like cell in patients with active systemic lupus erythematosus. Clin Immunol 209:108267","journal-title":"Clin Immunol"},{"key":"12451_CR47","doi-asserted-by":"publisher","unstructured":"DeDiego ML, Martinez-Sobrido L, Topham DJ (2019) Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses. J Virol 93(21). https:\/\/doi.org\/10.1128\/jvi.01159-19","DOI":"10.1128\/jvi.01159-19"},{"key":"12451_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","volume":"67","author":"M Postal","year":"2020","unstructured":"Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB (2020) Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol 67:87\u201394. https:\/\/doi.org\/10.1016\/j.coi.2020.10.014","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"12451_CR49","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1177\/0961203310371161","volume":"19","author":"G Obermoser","year":"2010","unstructured":"Obermoser G, Pascual V (2010) The interferon-alpha signature of systemic lupus erythematosus. Lupus 19(9):1012\u20131019. https:\/\/doi.org\/10.1177\/0961203310371161","journal-title":"Lupus"},{"issue":"2","key":"12451_CR50","doi-asserted-by":"publisher","first-page":"e70211","DOI":"10.1111\/exd.70211","volume":"35","author":"X Mi","year":"2026","unstructured":"Mi X, Lai K, Yan L, Yang J, Wu H, Wei S (2026) A Comprehensive Analysis of Type I Interferon Risk Gene Signatures in Systemic Lupus Erythematosus. Exp Dermatol 35(2):e70211. https:\/\/doi.org\/10.1111\/exd.70211","journal-title":"Exp Dermatol"},{"key":"12451_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jaut.2018.09.007","volume":"96","author":"S Joseph","year":"2019","unstructured":"Joseph S, George NI, Green-Knox B, Treadwell EL, Word B, Yim S, Lyn-Cook B (2019) Epigenome-wide association study of peripheral blood mononuclear cells in systemic lupus erythematosus: Identifying DNA methylation signatures associated with interferon-related genes based on ethnicity and SLEDAI. J Autoimmun 96:147\u2013157. https:\/\/doi.org\/10.1016\/j.jaut.2018.09.007","journal-title":"J Autoimmun"},{"issue":"11","key":"12451_CR52","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","volume":"75","author":"Z Zhao","year":"2016","unstructured":"Zhao Z, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, Liu Y, Jiang J, Luo S, Tan Y, Wu H, Renauer P, Del Mar Ayala Guti\u00e9rrez M, Castillo Palma MJ, Ortega Castro R, Fern\u00e1ndez-Rold\u00e1n C, Raya E, Faria R, Carvalho C, Alarc\u00f3n-Riquelme ME, Xiang Z, Chen J, Li F, Ling G, Zhao H, Liao X, Lin Y, Sawalha AH, Lu Q (2016) IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis 75(11):1998\u20132006. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208410","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"12451_CR53","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41390-024-03135-1","volume":"96","author":"J Wang","year":"2024","unstructured":"Wang J, Dang X, Wu X, Xiang Z, Li Y, Fu Y, Shen T (2024) DNA methylation of IFI44L as a potential blood biomarker for childhood-onset systemic lupus erythematosus. Pediatr Res 96(2):494\u2013501. https:\/\/doi.org\/10.1038\/s41390-024-03135-1","journal-title":"Pediatr Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12451-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:12:12Z","timestamp":1784812332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12451-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12451"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12451-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"17 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients participating in the study provided their informed consent, acknowledging that they understood the nature of the research and voluntarily agreed to participate.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Ethics Committee of University of Social Welfare and Rehabilitation Sciences (ID number: IR.USWR.REC.1402.041) and was conducted in compliance with the Declaration of Helsinki.","order":3,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1252"}}